Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment
NCT00226382
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
DRUG:
Pegylated Interferon-alfa-2a
Sponsor
Chinese University of Hong Kong
Collaborators
[object Object]